AM I having a herpes outbreak?!
Question: I was wondering if anyone could tell me if I was having a herpes outbreak or not. I I have recently, been getting pain in my vagina, butt, and calf. Almost a burning pain. I paid it no mind. And then the pain went away.Two days later I noticed a sore near my vagina. That only hurts when you touch it. I have no itching,, burning, discharge, fever,or any small blusters. I have gone to the doctor, but don't get my test results until friday. I am losing alot of sleep over this and just wanted to get others opinons.
Answers: I was wondering if anyone could tell me if I was having a herpes outbreak or not. I I have recently, been getting pain in my vagina, butt, and calf. Almost a burning pain. I paid it no mind. And then the pain went away.Two days later I noticed a sore near my vagina. That only hurts when you touch it. I have no itching,, burning, discharge, fever,or any small blusters. I have gone to the doctor, but don't get my test results until friday. I am losing alot of sleep over this and just wanted to get others opinons.
I usually have a little soreness in my thigh and butt (feels like a sore muscle) just before I feel tingling, then see a herpes outbreak.....so I'm not positive - mostly because I also have alot of itching
I've never had an outbreak that doesn't itch (right before the blisters and during)
Have you ever had this happen before? In the same spot? (it usually recurrs in the same spot - or closeby)
I'd have a Dr do the swab test to see if those sores are positive
"I'm a cancer physician. I primarily treat female cancer and certainly encourage my patients who are undergoing chemotherapy and radiation therapy to take transfer factor. It helps to modulate the immune system and is great for overall health. I have patients with chronic herpes infections who are taking transfer factor on a regular basis. These patients have reported a reduction in the number of outbreaks. I've also had patients with chronic yeast infections consuming transfer factor and are reporting improvement as well. Transfer factor is a science-based product with excellent data from a variety of researchers."
Duane Townsend, MD
ara.wow@hotmail.com sales
ABSTRACT
Transfer Factor in Dermatovenerology
S.G. Luikova, O.B. Nyemchanyinova, E.V. Chernikova, Iu.P. Gichev
Novosibirsk State Medical Academy;
Research Center for Clinical and Experimental Medicine SD RAMS, Novosibirsk
INTRODUCTION: According to current theories psoriasis is complicated by recurrent herpes infection, which brings about the suppression of interferon production and suppressed T-cellular immunity. This necessitates carrying out the immune status correction in addition to specific antiviral therapy. With this in mind we undertook the evaluation of the clinical effectiveness of transfer factors in this group of patients with psoriasis who also suffer from recurrent genital herpes.
OBJECTIVE: The aim of this investigation was to study the effects of enhanced transfer factors in a complex treatment of patients with psoriasis and recurrent genital herpes. METHODOLOGY 1: This study was initially conducted with 8 patients with exudative psoriasis, 5 children age 9-14 and 3 adults, ages 19-46. Four of these patients were manifesting dermatosis for the first time. All patients had widely distributed eruptions. Since traditional methods of treatment were not effective enough, we added enhanced transfer factors from bovine colostrum. The product was administered according to the following scheme: 4 capsules daily for 14 days and then 4 capsules twice a week for 14 days. The product was obtained from 4Life Research, USA. The clinical effectiveness of the product was evaluated. RESULTS 1: By the end of the course of treatment 7 patients demonstrated a marked improvement of skin condition. We prolonged treatment in only one patient for an additional two weeks. This patient has suffered from psoriasis since 1998 and exhibited signs of arthropathy. METHODOLOGY 2: We continued the study with an additional 9 patients, ages 18-38, with disease duration of 6 months to 5 years and that had suffered from severe (only several days to six weeks remission) or moderate severity (2 to 3 months remission) courses of the disease. During the recurrent course of the disease the majority of patients received antiviral (acyclovir) and non-specific immunomodulating drugs, biogenic stimulators and others, which in the majority of cases resulted in only a slight prolongation of the remission period. Enhanced transfer factors were given as a monotherapy to the patients during periods of genital herpes relapse according to the following scheme: 4 capsules daily for 2 weeks, then 4 capsules 3 times a week and in the following 2 weeks 4 capsules twice a week. The therapeutic effectiveness of the product was evaluated according to the duration of remission and the duration and severity of relapses as compared with the course of treatment without the use of transfer factors. RESULTS 2: Seven of nine patients receiving transfer factors demonstrated stable antirecurrent effects. Two patients had a relapse on the 2nd and the 4th weeks of the treatment, but it was of an abortive nature and did not affect quality of life. Pain acuteness in these instances was less pronounced than during the previous relapses. In the following 6 weeks the patients demonstrated stable clinical remission. CONCLUSION: We concluded that the use of enhanced transfer factors in patients with psoriasis and recurrent genital herpes gave improved clinical results which prompts the expediency of further clinical studies.
ara.wow@hotmail.com sales
When to Use transfer factor
How will a person know if transfer factor will be beneficial for him/her? It is important to be tested for a variety of different pathogens, to determine potential causative factors. If the test comes back positive, the patient should discuss the use of transfer factors with his/her physician. Certain conditions, for example, Chronic Fatigue Syndrome, may be triggered by a variety of pathogens. Research has indicated that several viruses may be playing a causative role. These include several members of the herpes virus family, all known to establish life-long residence in the infected individual. Many published clinical and research studies have indicated that there may be some relationships or involvement in CFS with the following pathogens: Herpes Virus Six (varients 6A and 6B), Epstein Barr Virus (EBV), and Cytomegalovirus (CMV).
transfer factor will not remove or